Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Depreciation & Amortization (CF) came in at $2.2 million in Q1 2026, down 27.83% year-on-year from $3.1 million in Q1 2025, and down 5.86% on a QoQ basis from $2.4 million in Q4 2025.
Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $2.2 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 27.83% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 21.79% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, down 15.02% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $2.2 million, down from $2.4 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for PLNH reached as high as $3.6 million in Q4 2024 and fell as low as $2.2 million in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
- Across the five-year window, Depreciation & Amortization (CF) jumped 173.95% in 2022 and tumbled 34.12% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $3.1 million in 2022, then slipped by 4.5% to $3.0 million in 2023, then rose by 21.03% to $3.6 million in 2024, then tumbled by 34.12% to $2.4 million in 2025, then slipped by 5.86% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $2.2 million in Q1 2026, $2.4 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Dec 31, 2023 | 2.96 Mn |